Literature DB >> 27619970

Is the efficacy of sacral nerve stimulation for faecal incontinence dependent on the number of active electrode poles achieved during permanent lead insertion?

J Duelund-Jakobsen1, L Lundby2, P-A Lehur3, V Wyart3, S Laurberg2, S Buntzen2.   

Abstract

AIM: Sacral nerve stimulation (SNS) is effective for faecal incontinence (FI). Little is known about the relationship between the implantation technique and the functional outcome. This study aimed to explore the relationship between the numbers of active electrode poles (AEP) achieved during permanent lead placement and subsequent function, therapeutic amplitude and the need for extra appointments between scheduled follow-up visits.
METHOD: One hundred and eighty-six patients with FI who underwent permanent implantation between May 2009 and March 2015 with a tined (barbed) lead (3093/3080, Medtronic) using the straight stylet were registered on the European two-centre SNS prospective database (SNSPD). Correlation between the number of AEP, function, stimulation amplitude and the need for extra visits was analysed.
RESULTS: The numbers of patients having an intra-operative motor response on stimulation of one, two, three and four poles were 18 (9.7%), 75 (40.3%), 61 (32.8%) and 32 (17.2%). The Wexner incontinence score was significantly reduced from 15 (±2.8) at baseline to 9.2 (±4.8) at the latest follow-up after a mean 878 ± 561 days (SD; P < 0.001). No correlation was found between the number of AEP and the functional outcome (P > 0.05). Patients with four-AEP had a reduced therapeutic amplitude up to 289 (±146) days of follow-up (P < 0.03). The number of AEP did not influence the need for extra follow-up visits (P < 0.223).
CONCLUSION: The functional outcome and number of extra visits after SNS for FI did not depend on the number of AEP achieved. The therapeutic amplitude was reduced during the first postoperative year if four AEP were achieved during lead placement. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Sacral nerve stimulation; faecal incontinence; implantation method; incontinence; sacral nerve modulation

Mesh:

Year:  2016        PMID: 27619970     DOI: 10.1111/codi.13509

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

Review 1.  [Sacral nerve modulation in coloproctology].

Authors:  M Gelos; M Niedergethmann
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 2.  Electrophysiological Basis of Fecal Incontinence and Its Implications for Treatment.

Authors:  Elroy Patrick Weledji
Journal:  Ann Coloproctol       Date:  2017-10-31

Review 3.  Programming Algorithms for Sacral Neuromodulation: Clinical Practice and Evidence-Recommendations for Day-to-Day Practice.

Authors:  Paul A Lehur; Michael Sørensen; Thomas C Dudding; Charles H Knowles; Stefan de Wachter; Stefan Engelberg; Klaus E Matzel
Journal:  Neuromodulation       Date:  2020-03-09

4.  Standardized fluoroscopy-guided implantation technique enables optimal electrode placement in sacral neuromodulation: a cadaver study.

Authors:  C Müller; L F Reissig; S Argeny; W J Weninger; S Riss
Journal:  Tech Coloproctol       Date:  2020-11-19       Impact factor: 3.781

5.  The effect of the number of active electrode poles during tined lead placement on long-term efficacy of sacral neuromodulation in patients with faecal incontinence.

Authors:  R Assmann; S O Breukink; S A P Caubergh; L P S Stassen; S M J van Kuijk; J Melenhorst
Journal:  Colorectal Dis       Date:  2020-07-22       Impact factor: 3.917

Review 6.  Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice.

Authors:  Thomas C Dudding; Paul A Lehur; Michael Sørensen; Stefan Engelberg; Maria Paola Bertapelle; Emmanuel Chartier-Kastler; Karel Everaert; Philip Van Kerrebroeck; Charles H Knowles; Lilli Lundby; Klaus E Matzel; Arantxa Muñoz-Duyos; Mona B Rydningen; Stefan de Wachter
Journal:  Neuromodulation       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.